AAAAAA
Results:
1-13
|
Results: 13
Authors:
WURTHMANN C
GREGOR J
SCHWARZ A
BAUMANN B
EFFENBERGER O
DOHRING W
BOGERTS B
Citation: C. Wurthmann et al., QUALITATIVE ASSESSMENT OF BRAIN MORPHOLOGY IN AGORAPHOBIA, Fortschritte der Neurologie, Psychiatrie, 66(9), 1998, pp. 427-431
Authors:
ULRICH S
WURTHMANN C
BROSZ M
MEYER FP
Citation: S. Ulrich et al., THE RELATIONSHIP BETWEEN SERUM CONCENTRATION AND THERAPEUTIC EFFECT OF HALOPERIDOL IN PATIENTS, Clinical pharmacokinetics, 34(3), 1998, pp. 227-263
Authors:
WURTHMANN C
GREGOR J
BAUMANN B
EFFENBERGER O
DOHRING W
BOGERTS B
Citation: C. Wurthmann et al., QUALITATIVE ASSESSMENT OF BRAIN MORPHOLOGY IN PANIC DISORDER, Nervenarzt, 69(9), 1998, pp. 763-768
Authors:
WURTHMANN C
BOGERTS B
GREGOR J
BAUMANN B
EFFENBERGER O
DOHRING W
Citation: C. Wurthmann et al., FRONTAL CSF ENLARGEMENT IN PANIC DISORDER - A QUALITATIVE CT-SCAN STUDY, PSYCHIATRY RESEARCH-NEUROIMAGING, 76(2-3), 1997, pp. 83-87
Authors:
PESTER U
SCHWARZ A
LERCHE J
BROSZ M
KROPF S
ULRICH S
BOGERTS B
WURTHMANN C
Citation: U. Pester et al., INTERCORRELATION OF PSYCHOPATHOLOGICAL, M ORPHOLOGICAL, NEUROPHYSIOLOGICAL AND PSYCHOMETRIC PARAMETERS IN SCHIZOPHRENIC-PATIENTS, Fortschritte der Neurologie, Psychiatrie, 65(7), 1997, pp. 297-303
Authors:
WURTHMANN C
KLIESER E
LEHMANN E
Citation: C. Wurthmann et al., SIDE-EFFECTS OF LOW-DOSE NEUROLEPTICS AND THEIR IMPACT ON CLINICAL OUTCOME IN GENERALIZED ANXIETY DISORDER, Progress in neuro-psychopharmacology & biological psychiatry, 21(4), 1997, pp. 601-609
Authors:
WURTHMANN C
KLIESER E
LEHMANN E
KRAUTH J
Citation: C. Wurthmann et al., SINGLE-SUBJECT EXPERIMENTS TO DETERMINE INDIVIDUALLY DIFFERENTIAL-EFFECTS OF ANXIOLYTICS IN GENERALIZED ANXIETY DISORDER, Neuropsychobiology, 33(4), 1996, pp. 196-201
Authors:
WURTHMANN C
BOGERTS B
FALKAI P
Citation: C. Wurthmann et al., BRAIN MORPHOLOGY ASSESSED BY COMPUTED-TOMOGRAPHY IN PATIENTS WITH GERIATRIC DEPRESSION, PATIENTS WITH DEGENERATIVE DEMENTIA, AND NORMAL CONTROL SUBJECTS, PSYCHIATRY RESEARCH-NEUROIMAGING, 61(2), 1995, pp. 103-111
Authors:
WURTHMANN C
KLIESER E
LEHMANN E
Citation: C. Wurthmann et al., DIFFERENTIAL THERAPY IN GENERALIZED ANXIE TY DISORDERS - 30 SINGLE-CASE EXPERIMENTS, Fortschritte der Neurologie, Psychiatrie, 63(8), 1995, pp. 303-309
Authors:
WURTHMANN C
BONDICK I
Citation: C. Wurthmann et I. Bondick, VALIDITY OF THE NEUROETHOLOGICAL MODEL OF OBSESSIVE-COMPULSIVE DISORDER, Fortschritte der Neurologie, Psychiatrie, 63(3), 1995, pp. 121-125
Authors:
WURTHMANN C
KLIESER E
LEHMANN E
Citation: C. Wurthmann et al., INTERACTION OF THERAPEUTIC EFFECTS AND SI DE-EFFECTS IN PHARMACOTHERAPY OF GENERALIZED ANXIETY DISORDERS WITH LOW-DOSAGE FLUSPIRILENE, Fortschritte der Neurologie, Psychiatrie, 63(2), 1995, pp. 72-77
Authors:
WURTHMANN C
KLIESER E
LEHMANN E
PESTER U
Citation: C. Wurthmann et al., TEST THERAPY IN THE TREATMENT OF GENERALIZED ANXIETY DISORDERS WITH LOW-DOSE FLUSPIRILENE, Progress in neuro-psychopharmacology & biological psychiatry, 19(6), 1995, pp. 1049-1060
Authors:
KLIESER E
LEHMANN E
KINZLER E
WURTHMANN C
HEINRICH K
Citation: E. Klieser et al., RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL OF RISPERIDONE VERSUS CLOZAPINE IN PATIENTS WITH CHRONIC-SCHIZOPHRENIA, Journal of clinical psychopharmacology, 15(1), 1995, pp. 45-51
Risultati:
1-13
|